Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Overview of attention for article published in Cardiovascular Diabetology, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 23,130 followers.

This #EHUikerketa discusses the rationale and clinical relevance for Cardiologists of the newly proposed MAFLD definition. https://t.co/Kt8EDgyTut

RT @Office_j: 【備忘】 Cardiovasc Diabetol誌に、NAFLDを”MAFLD” [Metabolic dysfunction-associated fatty liver disease] というCVリスク因子として扱うべしとする。治療薬として可…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.